Is Tenofovir Superior to Entecavir in Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B? The Controversy Continues

被引：10
|
作者：
Lampertico, Pietro [1 ]
Papatheodoridis, George V. [2 ]
机构：
[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, CRC AM & A Migliavacca Ctr Study Liver Dis, Via F Sforza 35, I-20122 Milan, Italy
[2] Univ Athens, Sch Med, Dept Gastroenterol, Gen Hosp Athens Laiko, Athens, Greece
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 01期
关键词：
DISOPROXIL FUMARATE; HCC; THERAPY;
D O I：
10.1053/j.gastro.2019.11.007
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：42 / 44
页数：4
相关论文
共 50 条
  • [21] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Jung Woo Shin
    Joonho Jeong
    Seok Won Jung
    Seung Bum Lee
    Bo Ryung Park
    Min-Ju Kim
    Eun Ji Park
    Neung Hwa Park
    Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
  • [22] OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDERGOING ENTECAVIR OR TENOFOVIR TREATMENT
    Lee, Chieh-Ju
    Su, Chien-Wei
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    HEPATOLOGY, 2019, 70 : 578A - 579A
  • [23] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [24] Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B
    Facciorusso, Antonio
    Cincione, Ivan
    Sacco, Rodolfo
    LIVER CANCER, 2021, 10 (03) : 285 - 286
  • [25] TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B
    Hsu, Yao-Chun
    Wong, Grace Lai-Hung
    Chen, Chien Hung
    Peng, Cheng-Yuan
    Yeh, Ming-Lun
    Cheung, Ka-Shing
    Toyoda, Hidenori
    Huang, Chung-Feng
    Trinh, Huy N.
    Xie, Qing
    Enomoto, Masaru
    Liu, Li
    Yasuda, Satoshi
    Tanaka, Yasuhito
    Kozuka, Ritsuzo
    Tsai, Pei-Chien
    Huang, Yen-Tsung
    Wong, Christopher
    Huang, Rui
    Jang, Tyng-Yuan
    Hoang, Joseph
    Yang, Hwai-I
    Li, Jiayi
    Lee, Dong Hyun
    Takahashi, Hirokazu
    Zhang, Jianqing
    Ogawa, Eiichi
    Zhao, Changqing
    Liu, Chenghai
    Furusyo, Norihiro
    Eguchi, Yuichiro
    Wong, Clifford
    Wu, Chao
    Kumada, Takashi
    Yuen, Man-Fung
    Yu, Ming-Lung
    Nguyen, Mindie H.
    HEPATOLOGY, 2019, 70 : 290A - 291A
  • [26] Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
    Kamal, Faisal
    Khan, Muhammad Ali
    Ahmed, Aijaz
    Nair, Satheesh
    GUT, 2020, 69 (11) : 2054 - +
  • [27] Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B
    Yip, Terry C. F.
    Wong, Vincent Wai-Sun
    Tse, Yee-Kit
    Chan, Henry
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E128 - E128
  • [28] Tenofovir disoproxil fumarate is not associated with a lower risk of hepatocellular carcinoma compared to entecavir in patients with chronic hepatitis B
    Lee, Hye Won
    Kim, Seung Up
    HEPATOMA RESEARCH, 2022, 8
  • [29] Risk of Hepatocellular Carcinoma Decreases over Time in Chronic Hepatitis B Patients on Antiviral Therapy with Entecavir or Tenofovir
    Hsu, Yao-Chun
    Ho, Hsiu-Jon
    El-Serag, Hashem B.
    Lin, Jaw-Town
    Wu, Chun-Ying
    HEPATOLOGY, 2016, 64 : 56A - 56A
  • [30] The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
    Papatheodoridis, George V.
    Idilman, Ramazan
    Dalekos, George N.
    Buti, Maria
    Chi, Heng
    van Boemmel, Florian
    Luis Calleja, Jose
    Sypsa, Vana
    Goulis, John
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros
    Keskin, Onur
    Gatselis, Nikolaos
    Hansen, Bettina E.
    Lehretz, Maria
    de la Revilla, Juan
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Ioannis
    Galanis, Kostantinos
    Yurdaydin, Cihan
    Berg, Thomas
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L. A.
    Lampertico, Pietro
    HEPATOLOGY, 2017, 66 (05) : 1444 - 1453
12345